Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Frye

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|November 1, 1984
Studies on synthesis and anticancer activity of selected N-(2-fluoroethyl)-N-nitrosoureasT P Johnston, C L Kussner, R L Carter, et al.
Journal of Pharmaceutical Sciences|June 1, 1984
Synthesis and properties of some 13-cis- and all-trans-retinamidesY F Shealy, J L Frye, C A O'Dell, et al.
Neurology|July 1, 1989
Changes in survival after transient ischemic attacks: observations comparing the 1970s and 1980sG Howard, J K Brockschmidt, L A Rose, et al.
Anti-Cancer Drug Design|January 1, 1997
Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancerY F Shealy, J L Frye, J M Riordan, et al.
Anti-Cancer Drug Design|May 22, 1998
Retinyl substituted-benzyl ethers. Inhibition of mammary carcinogenesis by retinyl 3,4,5-trimethoxybenzyl ether (RTMBE)Y F Shealy, J L Frye, D L Hill, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|November 1, 1984
Studies on synthesis and anticancer activity of selected N-(2-fluoroethyl)-N-nitrosoureasT P Johnston, C L Kussner, R L Carter, et al.
Journal of Pharmaceutical Sciences|June 1, 1984
Synthesis and properties of some 13-cis- and all-trans-retinamidesY F Shealy, J L Frye, C A O'Dell, et al.
Neurology|July 1, 1989
Changes in survival after transient ischemic attacks: observations comparing the 1970s and 1980sG Howard, J K Brockschmidt, L A Rose, et al.
Anti-Cancer Drug Design|January 1, 1997
Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancerY F Shealy, J L Frye, J M Riordan, et al.
Anti-Cancer Drug Design|May 22, 1998
Retinyl substituted-benzyl ethers. Inhibition of mammary carcinogenesis by retinyl 3,4,5-trimethoxybenzyl ether (RTMBE)Y F Shealy, J L Frye, D L Hill, et al.
Pageof 2